Drug Scientists Slow to Adopt Open Source

By M.L. Baker  |  Posted 09-08-2005 Print Email

WEBINAR: On-Demand

Know the Risk: Digital Transformation's Impact on Your Business-Critical Applications REGISTER >

A surge in open-source technology has given many businesses more options for powerful, low-cost software. But the pharmaceutical industry remains well behind the curve.


 

Submit a Comment

Loading Comments...
Manage your Newsletters: Login Register